These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21393445)

  • 1. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
    Chen D; Reierstad S; Fang F; Bulun SE
    Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
    Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
    Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
    Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
    J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
    Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.
    Subbaramaiah K; Hudis C; Chang SH; Hla T; Dannenberg AJ
    J Biol Chem; 2008 Feb; 283(6):3433-3444. PubMed ID: 18083712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.
    Samarajeewa NU; Yang F; Docanto MM; Sakurai M; McNamara KM; Sasano H; Fox SB; Simpson ER; Brown KA
    Breast Cancer Res; 2013 Apr; 15(2):R30. PubMed ID: 23566437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
    Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
    Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
    J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jun proteins modulate the ovary-specific promoter of aromatase gene in ovarian granulosa cells via a cAMP-responsive element.
    Ghosh S; Wu Y; Li R; Hu Y
    Oncogene; 2005 Mar; 24(13):2236-46. PubMed ID: 15688015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
    Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity.
    Welter JF; Crish JF; Agarwal C; Eckert RL
    J Biol Chem; 1995 May; 270(21):12614-22. PubMed ID: 7759510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
    Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
    Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.
    Langer S; Singer CF; Hudelist G; Dampier B; Kaserer K; Vinatzer U; Pehamberger H; Zielinski C; Kubista E; Schreibner M
    Eur J Gynaecol Oncol; 2006; 27(4):345-52. PubMed ID: 17009623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
    Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.